BDR - Blonder Tongue Laboratories nosedives 37% on delisting notice from NYSE

Blonder Tongue Laboratories (NYSE:BDR) received notice from NYSE to delist the common stock as the company was unable to demonstrate that it had regained compliance. The company was unable to regain compliance with maintaining certain level of stockholder's equity if the company has a history of reported losses from continuing operations, by the end of the maximum 18-month compliance plan period. The period expired on December 10, 2021. Company intends to exercise its right to appeal the staff's determination. Stock slumps 37% during after market hours.

For further details see:

Blonder Tongue Laboratories nosedives 37% on delisting notice from NYSE